Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Roche Cobas TV/MG Test Gets CE-IVD Mark

Roche Cobas TV/MG Test Gets CE-IVD Mark

Jan 24, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Roche today announced it received the CE-IVD mark for the Cobas TV/MG test for use on the Cobas 6800/8800 systems.

The test allows for the direct detection of Trichomonas vaginalis and/or Mycoplasma genitalium DNA in symptomatic as well as asymptomatic patients. Roche launched the test today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Regulatory News & FDA Approvals

  1. FDA Declines to Review EUA for Chembio Diagnostics SARS-CoV-2 Antibody Test

  2. Will US Ever Get to Mass Testing for COVID-19?

    Premium

  3. BARDA Awards $12.7M to Chembio to Support FDA Submissions for Respiratory, SARS-CoV-2 Antigen Tests

  4. FDA Authorizes Use of Pooled Samples With CDC Coronavirus Test

  5. FDA Grants Emergency Use Authorization for Innovita Biological Coronavirus Antibody Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.